Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 112.

Brüstle, K; Lema, S; Komminoth, P; Weder, W; Vrugt, B; Jungraithmayr, W (2016). Placental transmogrification of the lung presenting as progressive symptomatic bullous emphysema. Thorax:2.

Niedzwiecki, M; Yamada, Y; Inci, I; Weder, W; Jungraithmayr, W (2016). Decrease of airway allergies after lung transplantation is associated with reduced basophils and eosinophils. Transplantation Proceedings, 48(6):2140-2146.

Rothschild, S I; Zippelius, A; Prince, S Savic; Gonzalez, M; Weder, W; Xyrafas, A; Rusterholz, C; Pless, M (2016). 129TiP: SAKK 16/14 - anti-PD-L1 antibody durvalumab (MEDI4736) in addition to neoadjuvant chemotherapy in patients with stage IIIA (N2) non-small cell lung cancer (NSCLC): a multicenter single-arm phase II trial. Journal of Thoracic Oncology, 11(4 Suppl):S112.

Caviezel, C; Franzen, D; Inci, I; Weder, W (2016). Emphysemchirurgie – State of the Art 2016. Zentralblatt für Chirurgie, 141(S 01):S26-S34.

Eberhardt, W E E; De Ruysscher, D; Weder, W; Le Péchoux, C; De Leyn, P; Hoffmann, H; Westeel, V; Stahel, R; Felip, E; Peters, S (2015). 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Annals of Oncology, 26(8):1573-1588.

Stahel, R A; Weder, W; Felley-Bosco, E; Petrausch, U; Curioni-Fontecedro, A; Schmitt-Opitz, I; Peters, S (2015). Searching for targets for the systemic therapy of mesothelioma. Annals of Oncology, 26(8):1649-1660.

Franzen, D; Schneiter, D; Weder, W; Kohler, M (2015). Impact of sedation technique on the diagnostic accuracy of endobronchial ultrasound-guided needle aspiration (EBUS-TBNA). Endoscopic Ultrasound:Epub ahead of print.

Echeverry, N; Ziltener, G; Barbone, D; Weder, W; Stahel, R A; Broaddus, V C; Felley-Bosco, E (2015). Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors. Cell Death and Disease, 6:e1757.

Kostron, A; Horn-Tutic, M; Franzen, D; Kestenholz, P; Schneiter, D; Opitz, I; Kohler, M; Weder, W (2015). Repeated lung volume reduction surgery is successful in selected patients. European Journal of Cardio-Thoracic Surgery, 48(5):710-715.

Curioni-Fontecedro, A; Soldini, D; Seifert, B; Eichmueller, T; Korol, D; Moch, H; Weder, W; Stahel, R (2014). A Comprehensive Analysis of Markers for Neuroendocrine Tumors of the Lungs Demonstrates Estrogen Receptor Beta to be a Prognostic Markers in SCLC Male Patients. Journal of Cytology & Histology:5:268.

Otterstrom, C; Soltermann, A; Opitz, I; Felley-Bosco, E; Weder, W; Stahel, R A; Triponez, F; Robert, J H; Serre-Beinier, V (2014). CD74: a new prognostic factor for patients with malignant pleural mesothelioma. British Journal of Cancer, 110(8):2040-2046.

Frauenfelder, T; Puhan, Milo A; Lazor, R; von Garnier, C; Bremerich, J; Niemann, T; Christe, A; Montet, X; Gautschi, O; Weder, W; Kohler, M (2014). Early detection of lung cancer: A statement from an expert panel of the Swiss university hospitals on lung cancer screening. Respiration, 87(3):254-264.

Inci, I; Schuurmans, M M; Kestenholz, P; Schneiter, D; Hillinger, S; Opitz, I; Boehler, A; Weder, W (2013). Long-term outcomes of bilateral lobar lung transplantation. European Journal of Cardio-Thoracic Surgery, 43(6):1220-1225.

Franzen, D; Schneiter, D; Weder, W; Kohler, M (2013). Nachsorge des kurativ operierten NSCLC. InFo Onkologie und Haematologie, 1(1):22-24.

Franzen, D; Schneiter, D; Weder, W; Kohler, M (2013). Nachsorge nach kurativ operierten NSCLC – viele Fragen sind noch offen. InFo Onkologie und Haematologie, 1(1):22-24.

Petrausch, U; Schuberth, P C; Hagedorn, C; Soltermann, A; Tomaszek, S; Stahel, R; Weder, W; Renner, C (2012). Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1). BMC Cancer, 12:615.

Weder, W (2012). Advances in surgery. Annals of Oncology, 23 Suppl:x43-x45.

Opitz, I; Weder, W (2012). Diagnostik und Therapie des malignen Pleuramesothelioms - von der Palliationzur kurativen Intention. Therapeutische Umschau. Revue thérapeutique, 69(7):401-5.

Schneiter, D; Weder, W (2012). Minimal-invasive Chirurgie beim Bronchuskarzinom - Möglichkeit und Limiten. Therapeutische Umschau. Revue thérapeutique, 69(7):406-10.

Jungraithmayr, W; Weder, W (2012). The technique of orthotopic mouse lung transplantation as a movie-improved learning by visualization. American Journal of Transplantation, 12(6):1624-1626.

Jungraithmayr, W; De Meester, I; Matheeussen, V; Baerts, L; Arni, S; Weder, W (2012). CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation. European Journal of Cardio-Thoracic Surgery, 41(5):1166-1173.

Hofer, M; Schmid, C; Benden, C; Speich, R; Inci, I; Weder, W; Boehler, A (2012). Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation. Journal of Cystic Fibrosis, 11(2):131-136.

Wiedl, T; Collaud, S; Hillinger, S; Arni, S; Burgess, C; Kroll, W; Schraml, P; Soltermann, A; Moch, H; Weder, W (2012). KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinoma. Cancer Genomics & Proteomics, 9(1):51-54.

Collaud, S; Lardinois, D; Tischler, V; Steinert, H C; Stahel, R; Weder, W (2012). Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery, 41(3):612-616.

Meerwein, C; Korom, S; Arni, S; Inci, I; Weder, W; Jungraithmayr, W (2011). The effect of low-dose continuous erythropoietin receptor activator in an experimental model of acute Cyclosporine A induced renal injury. European Journal of Pharmacology, 671(1-3):113-119.

Inci, I; Arni, S; Acevedo, C; Jungraithmayr, W; Inci, D; Vogt, P; Weder, W (2011). Surfactant alterations following donation after cardiac death donor lungs. Transplant International, 24(1):78-84.

Wiedl, T; Arni, S; Roschitzki, B; Grossmann, J; Collaud, S; Soltermann, A; Hillinger, S; Aebersold, R; Weder, W (2011). Activity-based proteomics: identification of ABHD11 and ESD activities as potential biomarkers for human lung adenocarcinoma. Journal of Proteomics, 74(10):1884-1894.

Langhammer, B; Inci, I; Weder, W (2011). Aktueller Stellenwert der Chirurgie in der Therapie der Lungentuberkulose. Therapeutische Umschau, 68(7):407-410.

Felley-Bosco, E; Opitz, I; Soltermann, A; Thies, S; Weder, W; Stahel, R A (2011). Asbestos-induced tissue regeneration and malignant pleural mesothelioma: Insights from developmental studies. In: Berhardt, L V. Advances in Medicine and Biology. Volume 34. Hauppauge NY, USA: Nova Science Publishers, 131-153.

Arbogast, S; Behnke, S; Opitz, I; Stahel, R A; Seifert, B; Weder, W; Moch, H; Soltermann, A (2011). Automated ERCC1 Immunohistochemistry in Non-small Cell Lung Cancer: Comparison of anti-ERCC1 Antibodies 8F1, D-10, and FL-297. Applied Immunohistochemistry & Molecular Morphology, 19(2):99-105.

Shi, Y; Hollenstein, A; Felley-Bosco, E; Fraefel, C; Ackermann, M; Soltermann, A; Weder, W; Stahel, R A; Pruschy, M; Opitz, I (2011). Bioluminescence imaging for in vivo monitoring of local recurrence mesothelioma model. Lung Cancer, 71(3):370-371.

Inci, I; Irani, S; Kestenholz, P; Benden, C; Boehler, A; Weder, W (2011). Donor predicted post-operative forced expiratory volume in one second predicts recipients' best forced expiratory volume in one second following size-reduced lung transplantation. European Journal of Cardio-Thoracic Surgery, 39(1):115-119.

Wagner, P L; Stiedl, A C; Wilbertz, T; Petersen, K; Scheble, V; Menon, R; Reischl, M; Mikut, R; Rubin, M A; Fend, F; Moch, H; Soltermann, A; Weder, W; Altorki, N K; Perner, S (2011). Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma. Lung Cancer, 74(1):118-123.

Zalunardo, M P; Thalmann, C; Seifert, Burkhardt; D'Cunja, J; Weder, W; Boehler, A; Spahn, D R (2011). Impact of preoperative right-ventricular function and platelet transfusion on outcome after lung transplantation. European Journal of Cardio-Thoracic Surgery, 39(4):538-542.

Sidi, R; Pasello, G; Opitz, I; Soltermann, A; Tutic, M; Rehrauer, H; Weder, W; Stahel, R A; Felley-Bosco, E (2011). Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis. European Journal of Cancer, 47(2):326-332.

Draenert, A; Marquardt, K; Inci, I; Soltermann, A; Weder, W; Jungraithmayr, W (2011). Ischaemia-reperfusion injury in orthotopic mouse lung transplants - a scanning electron microscopy study. International Journal of Experimental Pathology, 92(1):18-25.

Tischler, V; Pfeifer, M; Hausladen, S; Schirmer, U; Bonde, A K; Kristiansen, G; Sos, M L; Weder, W; Moch, H; Altevogt, P; Soltermann, A (2011). L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Molecular Cancer, 10:127.

Weder, W; Russi, E W (2011). Lung-volume reduction by airway bypass. Lancet, 378(9795):966-967.

Opitz, I; Erne, B V; Demirbas, S; Jetter, A; Seifert, Burkhardt; Stahel, R; Weder, W (2011). Optimized intrapleural cisplatin chemotherapy with a fibrin carrier after extrapleural pneumonectomy: a preclinical study. Journal of Thoracic and Cardiovascular Surgery, 141(1):65-71.

Frei, C; Opitz, I; Soltermann, A; Fischer, B; Moura, U; Rehrauer, H; Weder, W; Stahel, R; Felley-Bosco, E (2011). Pleural mesothelioma side populations have a precursor phenotype. Carcinogenesis, 32(9):1324-1332.

De Leyn, P; Muller, M R; Oosterhuis, J W A; Schmid, T; Choong, C C; Weder, W; Sokolow, Y (2011). Prospective European multicenter randomized trial of PleuraSeal for control of air leaks after elective pulmonary resection. Journal of Thoracic and Cardiovascular Surgery, 141(4):881-887.

Weder, W; Stahel, R A; Baas, P; Dafni, U; de Perrot, M; McCaughan, B C; Nakano, T; Pass, H I; Robinson, B W S; Rusch, V W; Sugarbaker, D J; van Zandwijk, N (2011). The MARS feasibility trial: conclusions not supported by data. Lancet Oncology, 12(12):1093-1094; author reply 1094.

Frauenfelder, T; Tutic, M; Weder, W; Götti, R P; Stahel, R A; Seifert, Burkhardt; Opitz, I (2011). Volumetry - an alternative to assess therapy response for malignant pleural mesothelioma? European Respiratory Journal, 38(1):162-168.

Weder, W (2010). Mesothelioma. Annals of Oncology, 21 Sup:vii326-vii333.

Scherpereel, A; Astoul, P; Baas, P; Berghmans, T; Clayson, H; de Vuyst, P; Dienemann, H; Galateau-Salle, F; Hennequin, C; Hillerdal, G; Le Pe'choux, C; Mutti, L; Pairon, J C; Stahel, R; van Houtte, P; van Meerbeeck, J; Waller, D; Weder, W (2010). Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Zhongguo fei ai za zhi = Chinese journal of lung cancer, 13(10):C23-C45.

Inci, I; Weder, W (2010). Airway complications after lung transplantation can be avoided without bronchial artery revascularization. Current Opinion in Organ Transplantation, 15(5):578-581.

Jungraithmayr, W; Kayser, G; Haberstroh, J; Weder, W; Korom, S (2010). An experimental approach toward chronic pulmonary allograft rejection: Orthotopic lung versus heterotopic tracheal segment transplantation in rats. Transplantation Proceedings, 42(7):2767-2770.

Stahel, R A; Weder, W; Lievens, Y; Felip, E (2010). Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 21(Suppl ):v126-v128.

Jungraithmayr, W; Vogt, P; Inci, I; Hillinger, S; Arni, S; Passlick, B; Korom, S; Weder, W (2010). A model of chronic lung allograft rejection in the rat. European Respiratory Journal, 35(6):1354-1363.

Weder, W; Collaud, S; Eberhardt, W E E; Hillinger, S; Welter, S; Stahel, R; Stamatis, G (2010). Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer. Journal of Thoracic and Cardiovascular Surgery, 139(6):1424-1430.

Benden, C; Inci, I; Weder, W; Boehler, A (2010). Size-reduced lung transplantation in children - an option worth to consider. Pediatric Transplantation, 14(4):529-533.

Crinò, L; Weder, W; van Meerbeeck, J; Felip, E (2010). Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 21 (S 5):v103-v115.

Jungraithmayr, W; De Meester, I; Matheeussen, V; Inci, I; Augustyns, K; Scharpé, S; Weder, W; Korom, S (2010). Inhibition of CD26/DPP IV attenuates ischemia/reperfusion injury in orthotopic mouse lung transplants: The pivotal role of vasoactive intestinal peptide. Peptides, 31(4):585-591.

Jungraithmayr, W; Inci, I; Bain, M; Hillinger, S; Korom, S; Weder, W (2010). Distribution of macrophages and T cells in syngrafts and allografts after experimental rat lung transplantation. Immunobiology, 215(3):206-214.

Schramm, A; Opitz, I; Thies, S; Seifert, B; Moch, H; Weder, W; Soltermann, A (2010). Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma. European Journal of Cardio-Thoracic Surgery, 37(3):566-572.

Erne, B V; Exner, C; Frauenfelder, T; Schmid, S; Weder, W (2010). A curious case of convulsion. Lancet, 375(9730):2050.

Mebazaa, A; Pitsis, A A; Rudiger, A; Toller, W; Longrois, D; Ricksten, S E; Bobek, I; De Hert, S; Wieselthaler, G; Schirmer, U; von Segesser, L K; Sander, M; Poldermans, D; Ranucci, M; Karpati, P C J; Wouters, P; Seeberger, M; Schmid, E R; Weder, W; Follath, F (2010). Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery. Critical Care, 14(2):201.

Soltermann, A; Opitz, I; Tischler, V; Thies, S; Morra, L; Stahel, R A; Weder, W; Moch, H (2010). EMT in NSCLC and malignant pleural mesothelioma. memo - Magazine of European Medical Oncology, 3(4):180-184.

Hillinger, S; Weder, W (2010). Extended surgical resection in stage III non-small cell lung cancer. Frontiers of Radiation Therapy and Oncology, 42:115-21.

Scherpereel, A; Astoul, P; Baas, P; Berghmans, T; Clayson, H; de Vuyst, P; Dienemann, H; Galateau-Salle, F; Hennequin, C; Hillerdal, G; Le Péchoux, C; Mutti, L; Pairon, J C; Stahel, R; van Houtte, P; van Meerbeeck, J; Waller, D; Weder, W (2010). Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for management of Malignant Pleural Mesothelioma. European Respiratory Journal, 35:479-495.

Collaud, S; Wiedl, T; Cattaneo, E; Soltermann, A; Hillinger, S; Weder, W; Arni, S (2010). Laser-capture microdissection impairs activity-based protein profiles for serine hydrolase in human lung adenocarcinoma. Journal of Biomolecular Techniques, 21(1):25-28.

Speich, R; Schneider, S; Hofer, M; Irani, S; Vogt, P; Weder, W; Boehler, A (2010). Mycophenolate mofetil reduces alveolar inflammation, acute rejection and graft loss due to bronchiolitis obliterans syndrome after lung transplantation. Pulmonary Pharmacology and Therapeutics, 23(5):445-449.

Inci, I; Erne, B; Arni, S; Jungraithmayr, W; Inci, D; Hillinger, S; Vogt, P; Leskosek, B; Weder, W (2010). Prevention of primary graft dysfunction in lung transplantation by N-acetylcysteine after prolonged cold ischemia. Journal of Heart and Lung Transplantation, 29(11):1293-1301.

Collaud, S; Remmen, F; Weder, W (2009). Transphrenic budding of the liver. Annals of Thoracic Surgery, 88(4):1364.

Stupp, R; Mayer, M; Kann, R; Weder, W; Zouhair, A; Betticher, D C; Roth, A D; Stahel, R A; Majno, S; Peters, S; Jost, L; Furrer, M; Thierstein, S; Schmid, R A; Hsu-Schmitz, S F; Mirimanoff, R O; Ris, H B; Pless, M (2009). Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. Lancet Oncology, 10(8):785-793.

De Conno, E; Steurer, M P; Wittlinger, M; Zalunardo, M P; Weder, W; Schneiter, D; Schimmer, R C; Klaghofer, R; Neff, T A; Schmid, E R; Spahn, D R; Roth Z'graggen, B; Urner, M; Beck-Schimmer, B (2009). Anesthetic-induced improvement of the inflammatory response to one-lung ventilation. Anesthesiology, 110(6):1316-1326.

Thurneysen, C; Opitz, I; Kurtz, S; Weder, W; Stahel, R A; Felley-Bosco, E (2009). Functional inactivation of NF2/merlin in human mesothelioma. Lung Cancer, 64(2):140-147.

Weder, W; Tutic, M; Bloch, K E (2009). Lung volume reduction surgery in nonheterogeneous emphysema. Thoracic Surgery Clinics, 19(2):193-199.

Pedretti, M; Soltermann, A; Arni, S; Weder, W; Neri, D; Hillinger, S (2009). Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: two human antibodies investigated in clinical trials in patients with cancer. Lung Cancer, 64(1):28-33.

Jungraithmayr, W M; Korom, S; Hillinger, S; Weder, W (2009). A mouse model of orthotopic, single-lung transplantation. Journal of Thoracic and Cardiovascular Surgery, 137(2):486-491.

Weder, W; Inci, I; Korom, S; Kestenholz, P B; Hillinger, S; Eich, C; Irani, S; Lardinois, D (2009). Airway complications after lung transplantation: risk factors, prevention and outcome. European Journal of Cardio-Thoracic Surgery, 35(2):293-298.

Soll, C; Hahnloser, D; Frauenfelder, T; Russi, E W; Weder, W; Kestenholz, P B (2009). The postpneumonectomy syndrome: clinical presentation and treatment. European Journal of Cardio-Thoracic Surgery, 35(2):319-324.

Ampollini, L; Soltermann, A; Felley-Bosco, E; Lardinois, D; Arni, S; Speck, R F; Weder, W; Opitz, I (2009). Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting. European Journal of Cardio-Thoracic Surgery, 35(3):457-462.

Tan, Q; Hillinger, S; van Blitterswijk, C A; Weder, W (2009). Intra-scaffold continuous medium flow combines chondrocyte seeding and culture systems for tissue engineered trachea construction. Interactive Cardiovascular and Thoracic Surgery, 8(1):27-30.

Weder, W; Tutic, M; Lardinois, D; Jungraithmayr, W; Hillinger, S; Russi, E W; Bloch, K E (2009). Persistent benefit from lung volume reduction surgery in patients with homogeneous emphysema. Annals of Thoracic Surgery, 87(1):229-237.

Huber, L C; Soltermann, A; Fischler, M; Gay, S; Weder, W; Russi, E W; Speich, R; Ulrich, S (2009). Caveolin-1 Expression and Hemodynamics in COPD Patients. Open Respiratory Medicine Journal, 3:73-78.

Korom, S; Boehler, A; Weder, W (2009). Immunosuppressive therapy in lung transplantation: state of the art. European Journal of Cardio-Thoracic Surgery, 35(6):1045-1055.

Stahel, R A; Weder, W (2009). Improving the outcome in malignant pleural mesothelioma: nonaggressive or aggressive approach? Current Opinion in Oncology, 21(2):124-130.

Jungraithmayr, W; Ji, L; Yang, L; Weder, W; Korom, S; Hersberger, M (2009). Increased T-bet to GATA-3 ratio during acute allograft rejection in the rat lung. Transplantation Proceedings, 41(10):4316-4320.

Stahel, R A; Felley-Bosco, E; Opitz, I; Weder, W (2009). Malignant pleural mesothelioma. Future Oncology, 5(3):391-402.

Stahel, R A; Weder, W; Felip, E (2009). Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 20 Sup:73-75.

Weder, W; Opitz, I; Stahel, R (2009). Multimodality strategies in malignant pleural mesothelioma. Seminars in Thoracic and Cardiovascular Surgery, 21(2):172-176.

Zhai, W; Jungraithmayr, W; De Meester, I; Inci, I; Augustyns, K; Arni, S; Hillinger, S; Scharpé, S; Weder, W; Korom, S (2009). Primary graft dysfunction in lung transplantation: the role of CD26/dipeptidylpeptidase IV and vasoactive intestinal peptide. Transplantation, 87(8):1140-1146.

Perner, S; Wagner, P L; Soltermann, A; LaFargue, C; Tischler, V; Weir, B A; Weder, W; Meyerson, M; Giordano, T J; Moch, H; Rubin, M A (2009). TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival. Journal of Pathology, 217(1):65-72.

Jungraithmayr, W; Oberreiter, B; De Meester, I; Wiedl, T; Inci, I; Bain, M; Augustyns, K; Hillinger, S; Scharpé, S; Weder, W; Korom, S (2009). The effect of organ-specific CD26/DPP IV enzymatic activity inhibitor-preconditioning on acute pulmonary allograft rejection. Transplantation, 88(4):478-485.

Tan, Q; El-Badry, A M; Contaldo, C; Steiner, R; Hillinger, S; Welti, M; Hilbe, M; Spahn, D R; Jaussi, R; Higuera, G; van Blitterswijk, C A; Luo, Q; Weder, W (2009). The effect of perfluorocarbon-based artificial oxygen carriers on tissue-engineered trachea. Tissue engineering. Part C, 15(9):2471-2480.

Hofer, M; Benden, C; Inci, I; Schmid, C; Irani, S; Speich, R; Weder, W; Boehler, A (2009). True survival benefit of lung transplantation for cystic fibrosis patients: the Zurich experience. Journal of Heart and Lung Transplantation, 28(4):334-339.

Soltermann, A; Tischler, V; Arbogast, S; Braun, J; Probst-Hensch, N M; Weder, W; Moch, H; Kristiansen, G (2008). Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clinical Cancer Research, 14(22):7430-7437.

Moser, C; Opitz, I; Zhai, W; Rousson, V; Russi, E W; Weder, W; Lardinois, D (2008). Autologous fibrin sealant reduces the incidence of prolonged air leak and duration of chest tube drainage after lung volume reduction surgery: a prospective randomized blinded study. Journal of Thoracic and Cardiovascular Surgery, 136(4):843-849.

Stahel, R; Felley-Bosco, E; Opitz, I; Weder, W (2008). Mesothelioma. In: Hansen, H. Lung Cancer Therapy Annual 6. New York: Informa Healthcare USA, Inc., 205-222.

Ribi, K; Bernhard, J; Schuller, J C; Weder, W; Bodis, S; Jörger, M; Betticher, D; Schmid, R A; Stupp, R; Ris, H B; Stahel, R A (2008). Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: feasibility and responsiveness to clinical changes. Lung Cancer, 61(3):398-404.

Weder, W (2008). Lung cancer: new opportunities - changing algorithm in staging. Annals of Oncology, 19(Suppl ):vii28-vii30.

Schneiter, D; Grodzki, T; Lardinois, D; Kestenholz, P B; Wojcik, J; Kubisa, B; Pierog, J; Weder, W (2008). Accelerated treatment of postpneumonectomy empyema: a binational long-term study. Journal of Thoracic and Cardiovascular Surgery, 136(1):179-185.

Weder, W; Hillinger, S (2008). Tumornachsorge beim Bronchuskarzinom – wie, wann, bei wem, durch wen? Therapeutische Umschau, 65(6):315-318.

Cardell, M; Jung, F J; Zhai, W; Hillinger, S; Welp, A; Manz, B; Weder, W; Korom, S (2008). Acute allograft rejection and immunosuppression: influence on endogenous melatonin secretion. Journal of Pineal Research, 44(3):261-266.

Zhai, W; Ge, J; Inci, I; Hillinger, S; Markus, C; Korom, S; Weder, W (2008). Simplified rat lung transplantation by using a modified cuff technique. Journal of Investigative Surgery, 21(1):33-37.

Inci, I; Ampollini, L; Arni, S; Jungraithmayr, W; Inci, D; Hillinger, S; Leskosek, B; Vogt, P; Weder, W (2008). Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. Journal of Heart and Lung Transplantation, 27(11):1229-1236.

Benden, C; Speich, R; Hofbauer, G F; Irani, S; Eich-Wanger, C; Russi, E W; Weder, W; Boehler, A (2008). Extracorporeal photopheresis after lung transplantation: a 10-year single-center experience. Transplantation, 86(11):1625-1627.

Chmiel, C; Speich, R; Hofer, M; Michel, D; Mertens, T; Weder, W; Boehler, A (2008). Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clinical Infectious Diseases, 46(6):831-839.

Inci, I; Arni, S; Inci, D; Zhai, W; Hillinger, S; Leskosek, B; Vogt, P; Weder, W (2008). Impact of topical cooling solution and prediction of pulmonary graft viability from non-heart-beating donors. Journal of Heart and Lung Transplantation, 27(9):1016-1022.

Stahel, R A; Weder, W; Felip, E (2008). Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 19(Suppl ):ii43-ii44.

Opitz, I; Soltermann, A; Abaecherli, M; Hinterberger, M; Probst-Hensch, N; Stahel, R; Moch, H; Weder, W (2008). PTEN expression is a strong predictor of survival in mesothelioma patients. European Journal of Cardio-Thoracic Surgery, 33(3):502-506.

Opitz, I; Kestenholz, P; Lardinois, D; Müller, M; Rousson, V; Schneiter, D; Stahel, R; Weder, W (2006). Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. European Journal of Cardio-Thoracic Surgery, 29(4):579-584.

Lardinois, D; Jung, F J; Opitz, I; Rentsch, K; Latkoczy, C; Vuong, V; Varga, Z; Rousson, V; Günther, D; Bodis, S; Stahel, R; Weder, W (2006). Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma. Journal of Thoracic and Cardiovascular Surgery, 131(3):697-703.

Tan, Q; Steiner, R; Hoerstrup, S P; Weder, W (2006). Tissue-engineered trachea: History, problems and the future. European Journal of Cardio-Thoracic Surgery, 30(5):782-786.

Lardinois, D; Banysch, M; Korom, S; Hillinger, S; Rousson, V; Boehler, A; Speich, R; Weder, W (2005). Extended donor lungs: eleven years experience in a consecutive series. European Journal of Cardio-Thoracic Surgery, 27(5):762-767.

Ulrich, S; Fischler, M; Pfammatter, T; Vogt, P; Weder, W; Boehler, A; Speich, R (2005). Multiple peripheral pulmonary artery stenoses in adults: a rare cause of severe pulmonary hypertension necessitating lung transplantation. Journal of Heart and Lung Transplantation, 24(11):1984-1987.

Aschkenasy, S V; Hofer, C K; Zalunardo, M P; Zaugg, M; Weder, W; Seifert, Burkhardt; Pasch, T; Zollinger, A (2005). Patterns of changes in arterial PO2 during one-lung ventilation: a comparison between patients with severe pulmonary emphysema and patients with preserved lung function. Journal of Cardiothoracic and Vascular Anesthesia, 19(4):479-84.

Holzmann, D; Speich, R; Kaufmann, T; Laube, I; Russi, E W; Simmen, D; Weder, W; Boehler, A (2004). Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: a 10-year experience. Transplantation, 77(1):134-136.

Speich, R; Nicod, L P; Aubert, J D; Spiliopoulos, A; Wellinger, J; Robert, J H; Stocker, R; Zalunardo, M; Gasche-Soccal, P; Boehler, A; Weder, W (2004). Ten years of lung transplantation in Switzerland: results of the Swiss Lung Transplant Registry. Swiss Medical Weekly, 134(1-2):18-23.

Dutly, A E; Inci, I; Hillinger, S; Zalunardo, M; Gaspert, A; Rousson, V; Seifert, Burkhardt; Weder, W (2003). Normal gas exchange after 30-h ischemia and treatment with phosphodiesterase inhibitor PDI747. European Journal of Cardio-Thoracic Surgery, 24(4):594-600.

Lardinois, D; Weder, W; Hany, T F; Kamel, E M; Korom, S; Seifert, Burkhardt; von Schulthess, G K; Steinert, H C (2003). Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. New England Journal of Medicine, 348(25):2500-2507.

This list was generated on Fri Sep 22 19:10:42 2017 CEST.